Tulex Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TULEX PHARMS INC, and what generic and branded alternatives to TULEX PHARMS INC drugs are available?
TULEX PHARMS INC has five approved drugs.
Summary for Tulex Pharms Inc
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Tulex Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tulex Pharms Inc | OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET;ORAL | 210125-001 | Sep 6, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Tulex Pharms Inc | CLOMIPRAMINE HYDROCHLORIDE | clomipramine hydrochloride | CAPSULE;ORAL | 210653-002 | Apr 3, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Tulex Pharms Inc | NAPROXEN | naproxen | TABLET, DELAYED RELEASE;ORAL | 216908-002 | May 31, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Tulex Pharms Inc | METHYLERGONOVINE MALEATE | methylergonovine maleate | TABLET;ORAL | 212233-001 | May 1, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Tulex Pharms Inc | CLOMIPRAMINE HYDROCHLORIDE | clomipramine hydrochloride | CAPSULE;ORAL | 210653-003 | Apr 3, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Tulex Pharms Inc | CLOMIPRAMINE HYDROCHLORIDE | clomipramine hydrochloride | CAPSULE;ORAL | 210653-001 | Apr 3, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
